These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3274909)

  • 1. Bay o 9867 (ciprofloxacin) in the treatment of urinary tract infections in elderly patients.
    Vellucci A; De Rosa F; Bernardini G; Di Vico B
    Riv Eur Sci Med Farmacol; 1988 Aug; 10(4):333-9. PubMed ID: 3274909
    [No Abstract]   [Full Text] [Related]  

  • 2. [The efficacy and tolerance of Bay-o-9867 (ciprofloxacin) in the treatment of infections of the urinary tract and of the lower respiratory tract].
    Quartieri F; Bolognesi S; Sconosciuto F
    Recenti Prog Med; 1994 Feb; 85(2):96-100. PubMed ID: 8184195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciprofloxacin in the treatment of urinary and respiratory tract infections in patients with chronic liver disease.
    Galante D; Esposito S; Barba D; Giusti G
    Chemioterapia; 1986 Oct; 5(5):322-6. PubMed ID: 3791479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of urinary tract infections with ciprofloxacin.
    Martorana G; Giberti C; Pizzorno R; Bonamini A; Oneto F; Curotto A; Soro O
    Clin Ther; 1988; 10(5):516-20. PubMed ID: 2856593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciprofloxacin (BAY 09867): clinical evaluation in urinary tract infections due to Pseudomonas aeruginosa.
    Guibert JM; Destree DM; Acar JF
    Chemioterapia; 1987 Jun; 6(2 Suppl):524-5. PubMed ID: 3151352
    [No Abstract]   [Full Text] [Related]  

  • 6. Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected].
    Iravani A; Tice AD; McCarty J; Sikes DH; Nolen T; Gallis HA; Whalen EP; Tosiello RL; Heyd A; Kowalsky SF
    Arch Intern Med; 1995 Mar; 155(5):485-94. PubMed ID: 7864704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of fecal flora.
    Daikos GL; Kathpalia SB; Sharifi R; Lolans VT; Jackson GG
    Am J Med; 1987 Apr; 82(4A):290-4. PubMed ID: 3555050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3-day therapy of uncomplicated lower urinary tract infections using low-dose ciprofloxacin].
    Prát V; Horcicková M; Matousovic K; Hatala M; Milotová Z
    Cas Lek Cesk; 1988 Nov; 127(48):1492-3. PubMed ID: 3242843
    [No Abstract]   [Full Text] [Related]  

  • 9. Ciprofloxacin versus cinoxacin in therapy of urinary tract infections. A randomized, double-blind trial.
    Goldstein EJ; Kahn RM; Alpert ML; Ginsberg BP; Greenway FL; Citron DM
    Am J Med; 1987 Apr; 82(4A):284-7. PubMed ID: 3555049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DUE of ciprofloxacin in the treatment of urinary tract infections in hospitalized patients.
    Dydek GJ; Souney PF; Matthews SJ
    Hosp Formul; 1992 Feb; 27(2):185-91. PubMed ID: 10116716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oral ciprofloxacin on fecal bacteria in elderly patients.
    Höffler U; Grünig F; Brehmer B
    J Chemother; 1989 Jul; 1(4 Suppl):617-8. PubMed ID: 16312558
    [No Abstract]   [Full Text] [Related]  

  • 12. [Observational study of therapy compliance in the treatment of uncomplicated urinary tract infections of the urinary tract with 500 mg ciprofloxacin suspension].
    García Victor F; Ferrero Doria R
    Arch Esp Urol; 2001 May; 54(4):313-20. PubMed ID: 11455764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ciprofloxacin in the treatment of chronic urinary tract infections].
    Sozzo E; Patruno P; Mastrangelo F
    Clin Ter; 1988 Mar; 124(5):363-8. PubMed ID: 2974346
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria.
    Preheim LC; Cuevas TA; Roccaforte JS; Mellencamp MA; Bittner MJ
    Am J Med; 1987 Apr; 82(4A):295-300. PubMed ID: 3555051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Maxaquin and ciprofloxacin in the treatment of complicated and recurrent urinary infections in adults].
    Savitskaia KI; Trapeznikova MF; Nekhorosheva AG; Solodilova OE; Nasonov VN; Dutov VV; Kalinin VN; Shanina AG; Rusanova EV
    Klin Med (Mosk); 1994; 72(2):38-42. PubMed ID: 8015241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of urinary tract infections with ciprofloxacin].
    Horcicková M; Prát V; Matousovic K; Hatala M; Liska M; Milotová Z
    Cas Lek Cesk; 1987 Sep; 126(39):1221-4. PubMed ID: 3664597
    [No Abstract]   [Full Text] [Related]  

  • 17. Ciprofloxacin in the treatment of complicated urinary tract infections.
    Naber K; Sörgel F
    Chemioterapia; 1987 Jun; 6(2 Suppl):522-3. PubMed ID: 3509488
    [No Abstract]   [Full Text] [Related]  

  • 18. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection.
    Iravani A; Klimberg I; Briefer C; Munera C; Kowalsky SF; Echols RM
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():67-75. PubMed ID: 10225575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy and tolerance of a five day course of ciprofloxacin in the treatment of urinary tract infection in women. Multicenter study].
    Prado V; Haristoy J; Montaño R; Castrillón M; Sepúlveda S; Zemelman R; Flaskamp R; Martínez J; Cumsille F
    Rev Med Chil; 1998 Jan; 126(1):49-55. PubMed ID: 9629754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of urinary tract infections with ciprofloxacin after renal transplantation.
    Grekas D; Thanos V; Dioudis C; Alivanis P; Tourkantonis A
    Int J Clin Pharmacol Ther Toxicol; 1993 Jun; 31(6):309-11. PubMed ID: 8335429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.